Natco Pharma Acquires 35.75% Stake in Adcock Ingram for $226 Million

Natco Pharma Limited has successfully completed the delisting of Adcock Ingram Holdings Limited from the Johannesburg Stock Exchange (JSE) and acquired 35.75% of Adcock Ingram in a transaction valued at approximately $226 million (ZAR 4 billion). This acquisition marks Natco Pharma's entry into the South African market and is expected to create new opportunities for growth and innovation. Adcock Ingram, established in 1891, is known for its trusted medication brands and has a significant market presence in South Africa.